- Home
- PALI vs SRZN Comparison
PALI vs SRZN Comparison
Compare PALI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PALI | SRZN |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.2M | 276.3M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PALI | SRZN |
|---|---|---|
| Price | $1.16 | $30.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | $9.80 | ★ $47.50 |
| AVG Volume (30 Days) | ★ 2.1M | 582.1K |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $260,000.00 | ★ $3,477,000.00 |
| Revenue This Year | N/A | $208.89 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $1.17 | $11.39 |
| 52 Week High | $2.86 | $37.83 |
Technical Indicators
Market Signals| Indicator | PALI | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 29.91 | 62.41 |
| Support Level | N/A | $23.31 |
| Resistance Level | $2.19 | $30.97 |
| Average True Range (ATR) | 0.11 | 2.52 |
| MACD | -0.02 | 0.32 |
| Stochastic Oscillator | 2.06 | 93.09 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).